Sponsor intelligence · OTHER
Clinical trials sponsored by
Vanderbilt-Ingram Cancer Center.
Real, source-linked trial activity for Vanderbilt-Ingram Cancer Center: 3 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 24, 2026. Source-linked, daily-refreshed.
PHASE2 2EARLY_PHASE1 1
Newest Vanderbilt-Ingram Cancer Center trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripa | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 42d ago | Lazarus: IT Therapy for ICANS | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 49d ago | Pilot Study of Casdatifan-Treated Refractory Renal Cell Carcinoma | EARLY_Ph 1 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Vanderbilt-Ingram Cancer Center (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.